Literature DB >> 22155497

Non-histone lysine acetylated proteins in heart failure.

Jean Michel Grillon1, Keven R Johnson, Kumar Kotlo, Robert S Danziger.   

Abstract

Both histone-acetylations and histone deacetylases have been shown to play a key role in cardiac remodeling. Recently, it has become abundantly clear that many non-histone proteins are modified by post-translational lysine acetylations and that these acetylations regulate protein activity, conformation, and binding. In the present study, non-histone acetylated proteins associated with heart failure were identified. Global screening for lysine acetylated proteins was performed using 2-dimensional gel electrophoresis coupled with immunoblotting with a primary monoclonal anti-acetyl-lysine antibody. Lysine acetylated proteins were compared in two rodent models of hypertensive heart failure, the Dahl salt-sensitive (SS) and spontaneously hypertensive heart failure prone (SHHF) rats with those in corresponding controls, i.e., the Dahl salt-resistant (SR) and W (W) rat strains, respectively. Forty-one and 66 acetylated proteins were detected in SS and SHHF failing hearts, respectively, but either not detected or detected with less abundance in corresponding control hearts. Twelve of these acetylated proteins were common to both models of heart failure. These were identified using matrix-assisted laser desorption/ionization time of flight (MALDI-TOF/TOF) mass spectrometry followed by Mascot Analysis and included mitochondrial enzymes: ATP synthase, long-chain acyl-CoA dehydrogenase, creatine kinase, malate dehydrogenase, and pyruvate dehydrogenase. The abundance of NAD-dependent deacetylase sirtuin-3 (Sirt3), a mitochondrial deacetylase was reduced in SS and SHHF failing hearts. This is the first description of non-histone protein acetylations associated with heart failure and raises the prospect that acetylations of mitochondrial proteins linked to reduced Sirt3 mediate, in part, metabolic changes in heart failure. Copyright Â
© 2011. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22155497      PMCID: PMC3684243          DOI: 10.1016/j.bbadis.2011.11.016

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  28 in total

Review 1.  Control of cardiac growth by histone acetylation/deacetylation.

Authors:  Johannes Backs; Eric N Olson
Journal:  Circ Res       Date:  2006-01-06       Impact factor: 17.367

2.  Substrate and functional diversity of lysine acetylation revealed by a proteomics survey.

Authors:  Sung Chan Kim; Robert Sprung; Yue Chen; Yingda Xu; Haydn Ball; Jimin Pei; Tzuling Cheng; Yoonjung Kho; Hao Xiao; Lin Xiao; Nick V Grishin; Michael White; Xiang-Jiao Yang; Yingming Zhao
Journal:  Mol Cell       Date:  2006-08       Impact factor: 17.970

3.  Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases.

Authors:  William C Hallows; Susan Lee; John M Denu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-21       Impact factor: 11.205

4.  Alterations of the mitochondrial respiratory chain in human dilated cardiomyopathy.

Authors:  A Buchwald; H Till; C Unterberg; R Oberschmidt; H R Figulla; V Wiegand
Journal:  Eur Heart J       Date:  1990-06       Impact factor: 29.983

5.  Enzymic analysis of cardiac biopsy material from patients with valvular heart-disease.

Authors:  T J Peters; I A Brooksby; M M Webb-Peploe; G Wells; B S Jenkins; D J Coltart
Journal:  Lancet       Date:  1976-02-07       Impact factor: 79.321

6.  Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2.

Authors:  Bjoern Schwer; Jakob Bunkenborg; Regis O Verdin; Jens S Andersen; Eric Verdin
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-20       Impact factor: 11.205

7.  Structural, functional, and molecular characterization of the SHHF model of heart failure.

Authors:  Jonathan R R Heyen; Eileen R Blasi; Kristen Nikula; Ricardo Rocha; Heather A Daust; Gregory Frierdich; John F Van Vleet; Pam De Ciechi; Ellen G McMahon; Amy E Rudolph
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-11       Impact factor: 4.733

8.  Proteomic analysis of organ-specific post-translational lysine-acetylation and -methylation in mice by use of anti-acetyllysine and -methyllysine mouse monoclonal antibodies.

Authors:  Hisako Iwabata; Minoru Yoshida; Yasuhiko Komatsu
Journal:  Proteomics       Date:  2005-12       Impact factor: 3.984

9.  Sir2-dependent activation of acetyl-CoA synthetase by deacetylation of active lysine.

Authors:  V J Starai; I Celic; R N Cole; J D Boeke; J C Escalante-Semerena
Journal:  Science       Date:  2002-12-20       Impact factor: 47.728

10.  Transition from compensatory hypertrophy to dilated, failing left ventricles in Dahl salt-sensitive rats.

Authors:  M Inoko; Y Kihara; I Morii; H Fujiwara; S Sasayama
Journal:  Am J Physiol       Date:  1994-12
View more
  26 in total

1.  SIRT3 deficiency exacerbates ischemia-reperfusion injury: implication for aged hearts.

Authors:  George A Porter; William R Urciuoli; Paul S Brookes; Sergiy M Nadtochiy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-04-18       Impact factor: 4.733

Review 2.  Using mitochondrial sirtuins as drug targets: disease implications and available compounds.

Authors:  Melanie Gertz; Clemens Steegborn
Journal:  Cell Mol Life Sci       Date:  2016-03-23       Impact factor: 9.261

Review 3.  Mitochondrial sirtuins in the heart.

Authors:  Heiko Bugger; Constantin N Witt; Christoph Bode
Journal:  Heart Fail Rev       Date:  2016-09       Impact factor: 4.214

Review 4.  Sirtuins and the circadian clock interplay in cardioprotection: focus on sirtuin 1.

Authors:  Sanjeev Kumar Soni; Priyoneel Basu; Muniyandi Singaravel; Ramaswamy Sharma; Seithikurippu R Pandi-Perumal; Daniel P Cardinali; Russel J Reiter
Journal:  Cell Mol Life Sci       Date:  2021-01-03       Impact factor: 9.261

Review 5.  Mitochondrial dysfunction in pathophysiology of heart failure.

Authors:  Bo Zhou; Rong Tian
Journal:  J Clin Invest       Date:  2018-08-20       Impact factor: 14.808

6.  Direct and indirect involvement of microRNA-499 in clinical and experimental cardiomyopathy.

Authors:  Scot J Matkovich; Yuanxin Hu; William H Eschenbacher; Lisa E Dorn; Gerald W Dorn
Journal:  Circ Res       Date:  2012-06-29       Impact factor: 17.367

7.  Cardiac PANK1 deletion exacerbates ventricular dysfunction during pressure overload.

Authors:  Timothy N Audam; Caitlin M Howard; Lauren F Garrett; Yi Wei Zheng; James A Bradley; Kenneth R Brittian; Matthew W Frank; Kyle L Fulghum; Miklós Pólos; Szilvia Herczeg; Béla Merkely; Tamás Radovits; Shizuka Uchida; Bradford G Hill; Sujith Dassanayaka; Suzanne Jackowski; Steven P Jones
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-09-17       Impact factor: 5.125

8.  Defining decreased protein succinylation of failing human cardiac myofibrils in ischemic cardiomyopathy.

Authors:  Hadi R Ali; Cole R Michel; Ying H Lin; Timothy A McKinsey; Mark Y Jeong; Amrut V Ambardekar; Joseph C Cleveland; Richard Reisdorph; Nichole Reisdorph; Kathleen C Woulfe; Kristofer S Fritz
Journal:  J Mol Cell Cardiol       Date:  2019-12-10       Impact factor: 5.000

9.  MicroRNA-195 Regulates Metabolism in Failing Myocardium Via Alterations in Sirtuin 3 Expression and Mitochondrial Protein Acetylation.

Authors:  Xiaokan Zhang; Ruiping Ji; Xianghai Liao; Estibaliz Castillero; Peter J Kennel; Danielle L Brunjes; Marcus Franz; Sven Möbius-Winkler; Konstantinos Drosatos; Isaac George; Emily I Chen; Paolo C Colombo; P Christian Schulze
Journal:  Circulation       Date:  2018-01-12       Impact factor: 29.690

10.  Sirt1 improves heart failure through modulating the NF-κB p65/microRNA-155/BNDF signaling cascade.

Authors:  Bin Lin; Hui Zhao; Li Li; Zhenzhen Zhang; Nan Jiang; Xiaowei Yang; Tao Zhang; Bowen Lian; Yaokai Liu; Chi Zhang; Jiaxiang Wang; Feng Wang; Deguang Feng; Jing Xu
Journal:  Aging (Albany NY)       Date:  2020-11-18       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.